← Eichor
Study identifier: NCT07059091 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Condition: Chronic Obstructive Pulmonary Disease (COPD) · Allergies  ·  Sponsor: Johns Hopkins University

PhasePhase 2
Planned participants334
Who can joinAll sexes, 40 Years to no upper limit
Healthy volunteersNo

About this study

This research is being done to test if a drug called omalizumab can help people with Chronic Obstructive Pulmonary Disease (COPD) and allergies. Each participant will be in the study for about 16 months, including 1-3 months of screening, 12 months of receiving the study drug at a clinic, and a follow-up call one month after your final clinic visit.

This description comes directly from the study's public registry record.

Talk to the study team

Kayla Long  ·  410-502-9048  ·  klong33@jhu.edu

Heather Hazucha  ·  410-502-0585  ·  hhazuch1@jhu.edu

Always discuss trial participation with your own doctor first.

Locations (23)

University of AlabamaBirmingham, Alabama, United StatesNot Yet Recruiting
University of Arizona- TusconTucson, Arizona, United StatesNot Yet Recruiting
University of San FranciscoSan Francisco, California, United StatesNot Yet Recruiting
National Jewish HealthDenver, Colorado, United StatesNot Yet Recruiting
University of FloridaJacksonville, Florida, United StatesNot Yet Recruiting
University of Illinois at ChicagoChicago, Illinois, United StatesNot Yet Recruiting
Northwestern UniversityChicago, Illinois, United StatesNot Yet Recruiting
Rush University Medical CenterChicago, Illinois, United StatesNot Yet Recruiting
University of IowaIowa City, Iowa, United StatesNot Yet Recruiting
University of Kansas Medical CenterKansas City, Kansas, United StatesNot Yet Recruiting
Johns Hopkins UniversityBaltimore, Maryland, United StatesRecruiting
University of MichiganAnn Arbor, Michigan, United StatesNot Yet Recruiting

+ 11 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07059091